share_log

Keros Therapeutics Shares Are Trading Higher After the Company Was Selected as Part of a Deal to Boost an Oncology Pipeline With Eltritercept.

Benzinga ·  Dec 4, 2024 00:23
Keros Therapeutics Shares Are Trading Higher After the Company Was Selected as Part of a Deal to Boost an Oncology Pipeline With Eltritercept.
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment